WGNBSVFRMSVJOR-UHFFFAOYSA-N
C29H33F3N8O3 — CID 121280224
Data last refreshed: (MolForge compound catalog, from PubChem)
About WGNBSVFRMSVJOR-UHFFFAOYSA-N
WGNBSVFRMSVJOR-UHFFFAOYSA-N (PubChem CID 121280224) has the molecular formula C29H33F3N8O3 and a molecular weight of 598.63 g/mol. Its IUPAC name is N-[2-[2-(dimethylamino)ethyl-methylamino]-4-methoxy-5-[[4-(5-methoxy-3-methylindazol-1-yl)-5-(trifluoromethyl)pyrimidin-2-yl]amino]phenyl]prop-2-enamide.
Molecular Properties
| Compound Name | WGNBSVFRMSVJOR-UHFFFAOYSA-N |
|---|---|
| PubChem CID | 121280224 |
| Molecular Formula | C29H33F3N8O3 |
| Molecular Weight | 598.63 g/mol |
| Exact Mass | 598.26 |
| IUPAC Name | N-[2-[2-(dimethylamino)ethyl-methylamino]-4-methoxy-5-[[4-(5-methoxy-3-methylindazol-1-yl)-5-(trifluoromethyl)pyrimidin-2-yl]amino]phenyl]prop-2-enamide |
| SMILES | C=CC(=O)Nc1cc(Nc2ncc(C(F)(F)F)c(-n3nc(C)c4cc(OC)ccc43)n2)c(OC)cc1N(C)CCN(C)C |
| InChI | InChI=1S/C29H33F3N8O3/c1-8-26(41)34-21-14-22(25(43-7)15-24(21)39(5)12-11-38(3)4)35-28-33-16-20(29(30,31)32)27(36-28)40-23-10-9-18(42-6)13-19(23)17(2)37-40/h8-10,13-16H,1,11-12H2,2-7H3,(H,34,41)(H,33,35,36) |
| InChIKey | WGNBSVFRMSVJOR-UHFFFAOYSA-N |
| XLogP | 5.03 |
| TPSA | 109.67 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 11 |
| Heavy Atoms | 43 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 598.63 |
| LogP ≤ 5 | 5.03 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 10 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 121280224 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.